These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 17910652

  • 1. Epstein-Barr virus DNA load and seroconversion in pediatric renal transplantation with tacrolimus immunosuppression.
    Suzuki T, Ikezumi Y, Okubo S, Uchiyama M, Takahashi K, Shiraga H, Hattori M.
    Pediatr Transplant; 2007 Nov; 11(7):749-54. PubMed ID: 17910652
    [Abstract] [Full Text] [Related]

  • 2. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Nov; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
    Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML.
    Transplantation; 1999 Oct 15; 68(7):997-1003. PubMed ID: 10532541
    [Abstract] [Full Text] [Related]

  • 4. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.
    New Microbiol; 2003 Apr 15; 26(2):141-9. PubMed ID: 12737195
    [Abstract] [Full Text] [Related]

  • 5. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.
    Transpl Infect Dis; 2004 Mar 15; 6(1):15-22. PubMed ID: 15225222
    [Abstract] [Full Text] [Related]

  • 6. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation.
    Chen HS, Ho MC, Hu RH, Wu JF, Chen HL, Ni YH, Hsu HY, Jeng YM, Chang MH.
    J Formos Med Assoc; 2019 Sep 15; 118(9):1362-1368. PubMed ID: 30612881
    [Abstract] [Full Text] [Related]

  • 7. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 15; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 8. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.
    Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM.
    Transplantation; 2002 May 27; 73(10):1603-10. PubMed ID: 12042647
    [Abstract] [Full Text] [Related]

  • 9. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.
    J Pediatr Gastroenterol Nutr; 2001 Oct 27; 33(4):445-9. PubMed ID: 11698761
    [Abstract] [Full Text] [Related]

  • 10. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
    Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J, Reiter A, Wagner HJ.
    J Clin Virol; 2012 Mar 27; 53(3):186-94. PubMed ID: 22182950
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of Epstein-Barr virus load and antibody in pediatric renal transplant patients.
    Sato T, Fujieda M, Tanaka E, Miyamura M, Chikamoto H, Hisano M, Akioka Y, Ishiura Y, Dohno S, Maeda A, Hattori M, Wakiguchi H.
    Pediatr Int; 2008 Aug 27; 50(4):454-8. PubMed ID: 19143966
    [Abstract] [Full Text] [Related]

  • 12. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H.
    Transpl Int; 2002 Nov 27; 15(11):529-34. PubMed ID: 12461655
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation.
    Fukushima D, Sato K, Kawagishi N, Ohuchi N, Satomi S.
    Transplantation; 2015 Jan 27; 99(1):114-9. PubMed ID: 24846306
    [Abstract] [Full Text] [Related]

  • 14. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 27; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 15. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.
    Clin Transplant; 2006 Jan 27; 20(3):389-93. PubMed ID: 16824159
    [Abstract] [Full Text] [Related]

  • 16. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome.
    Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ.
    Transplantation; 2002 Aug 15; 74(3):367-72. PubMed ID: 12177616
    [Abstract] [Full Text] [Related]

  • 17. Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients.
    Ladfors SW, Lindahl JK, Hansson S, Brandström P, Andersson R, Jertborn M, Lindh M, Woxenius S, Friman V.
    Pediatr Nephrol; 2020 Mar 15; 35(3):427-439. PubMed ID: 31802220
    [Abstract] [Full Text] [Related]

  • 18. Asymptomatic high Epstein-Barr viral load carriage in pediatric renal transplant recipients.
    Tanaka E, Sato T, Ishihara M, Tsutsumi Y, Hisano M, Chikamoto H, Akioka Y, Dohno S, Maeda A, Hattori M, Wakiguchi H, Fujieda M.
    Pediatr Transplant; 2011 May 15; 15(3):306-13. PubMed ID: 21492352
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy.
    Kullberg-Lindh C, Saalman R, Olausson M, Herlenius G, Lindh M.
    Pediatr Transplant; 2017 Aug 15; 21(5):. PubMed ID: 28039929
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.
    Höcker B, Fickenscher H, Delecluse HJ, Böhm S, Küsters U, Schnitzler P, Pohl M, John U, Kemper MJ, Fehrenbach H, Wigger M, Holder M, Schröder M, Billing H, Fichtner A, Feneberg R, Sander A, Köpf-Shakib S, Süsal C, Tönshoff B.
    Clin Infect Dis; 2013 Jan 15; 56(1):84-92. PubMed ID: 23042966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.